The Molecular Map of Obsessive-Compulsive Disorder Points to New Pain Pathways
A groundbreaking study published in Psychological Medicine offers a multiscale investigation into the brain abnormalities of obsessive-compulsive disorder (OCD). Researchers analyzed 100 medication-free OCD patients and 90 healthy controls using multimodal imaging, identifying significant abnormalities in structure–function coupling (SFC) within the right temporoparietal junction. This neural dysregulation was linked to the expression profiles of 2,421 genes and showed a strong spatial correlation with the serotonin neurotransmitter system. Gene enrichment analysis revealed these genes are involved in critical processes like synaptic signaling and neuronal development, providing a potential molecular blueprint for the disorder’s pathology.
Study Significance: For pain medicine specialists, this research is methodologically adjacent, offering a powerful framework for investigating chronic pain conditions like fibromyalgia or complex regional pain syndrome (CRPS), which also involve central sensitization and neurotransmitter dysregulation. The identified link between structural-functional coupling, gene expression, and the serotonin system provides a concrete model for exploring the neurobiological underpinnings of nociplastic pain. This could accelerate the development of targeted, non-opioid adjuvant analgesics that move beyond symptom management to address core pathological mechanisms.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
